Abstract
Classical Hodgkin's lymphoma (cHL) is an unusual lymphoid neoplasm, and nearly 50% of patients still relapse after standard therapy. Programmed cell d......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
